They dont contain any active ingredient that GLP-1 medications do
1,15 Hyperglycemia-induced metabolic pathways Polyol pathway activation In a hyperglycemic state, excess glucose is shunted into the polyol pathway, where aldose reductase catalyzes its reduction to sorbitol, which in turn is oxidized to fructose by sorbitol dehydrogenase
DR and its effect on the insulin/IGF-1 system The importance of the insulin/IGF-1 system for the antitumor effects of DR is exemplified by the fact that in vivo IGF-1 administration 94, 95, 96 completely rescued CR-sensitive tumors from CR-induced growth inhibition
Melanotan II starting phase Commonly discussed at roughly 0.251 mg injected daily, often based on body weight, before tapering to just one or two doses a week
Additional information Related products GH & Regeneration Research Peptides CJC-1295 With DAC (1 Vial) $49.99 Select options This product has multiple variants